Sodium Reduction, miRNA Profiling and CVD Risk in Untreated Hypertensives: a Randomized, Double-Blind, Placebo-Controlled Trial

Scientific Reports
Li ChenHaidong Zhu

Abstract

Sodium reduction decreases blood pressure (BP) and cardiovascular mortality. However, the underlying molecular mechanisms are not well understood. We tested the hypothesis that reduction of sodium intake would change miRNA expression in hypertensive patients, and those changes would be associated with improved cardiovascular phenotypes. A whole genome RNA sequencing was performed in paired serum samples collected at the end of usual sodium intake and reduced sodium intake periods from 10 (age 56.8 ± 8.9) untreated black male hypertensives, selected from a randomized crossover trial of sodium reduction as the discovery cohort. Validation was carried out by the PCR Serum/Plasma Focus panel profiling in paired samples in all 64 (50% males, age 50.2 ± 9.5) untreated black hypertensives from the same trial. Fifteen respondent miRNAs were identified in the discovery stage. miR-143-3p was replicated. Sodium reduction up-regulated miR-143-3p. The increase in miR-143-3p was associated with the reduction of BP and arterial stiffness and the increase in skin capillary density. In conclusion, dietary sodium reduction alters circulating miRNA expressions, and those miRNA changes are associated with reduced BP and improved arterial complianc...Continue Reading

References

May 1, 2007·Nature Medicine·Alessandra CarèGianluigi Condorelli
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Mar 27, 2010·Journal of the American College of Cardiology·Charalambos VlachopoulosChristodoulos Stefanadis
Apr 27, 2010·Current Drug Targets·Angelika BonauerStefanie Dimmeler
Apr 21, 2011·Circulation. Cardiovascular Genetics·Ashraf Yusuf RangrezLaurent Metzinger
Oct 4, 2012·The Journal of Clinical Endocrinology and Metabolism·Dwi Setyowati KarolinaKandiah Jeyaseelan
Apr 6, 2013·BMJ : British Medical Journal·Nancy J AburtoJoerg J Meerpohl
Jun 4, 2013·Clinical Biochemistry·John J GildeaRobin A Felder
Jan 15, 2014·Circulation·Nancy R CookPaul K Whelton
Jun 18, 2014·International Journal of Molecular Sciences·Tong-Shuai GuoDan Wang
Aug 5, 2014·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Qi GuXiao-Ze Wang
Sep 27, 2014·American Journal of Hypertension·Feng J He, Graham A MacGregor
Feb 1, 2015·Gene·Ismail Dogu KilicH Eren Bostancı
Nov 12, 2016·Current Hypertension Reports·Miruna NemeczAdriana Georgescu
Mar 9, 2017·American Journal of Physiology. Endocrinology and Metabolism·Ingrid DahlmanAgné Kulyté

❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-seq
PCR
chip

Software Mentioned

Cytoscan
Roche LC
Stata
KK
Exiqon
R
LinReg
CapiScope

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.